Evaluation of Outcomes of Coronary Artery Bypass Grafting.
Launched by ST. PETERSBURG STATE PAVLOV MEDICAL UNIVERSITY · Dec 20, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the outcomes of a surgery called coronary artery bypass grafting (CABG), which is often used to treat people with ischemic heart disease. This condition occurs when the heart doesn’t get enough blood due to blocked arteries. The trial is currently looking for participants, and anyone aged between 10 and 29 years old with ischemic heart disease who needs this surgery may be eligible to join. However, individuals with valve disease will not be able to participate.
If you or someone you know is considering participating in this trial, you can expect to contribute to important research that could help improve the understanding of CABG outcomes. Participants will undergo the surgery as part of their normal treatment, and their recovery and results will be closely monitored. This trial aims to gather valuable information that could benefit future patients facing similar heart conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ischemic heart disease with indications for coronary artery bypass grafting.
- Exclusion Criteria:
- • valve disease
About St. Petersburg State Pavlov Medical University
St. Petersburg State Pavlov Medical University is a prestigious institution renowned for its contributions to medical education, research, and clinical practice. With a legacy dating back to 1897, the university is committed to advancing healthcare through innovative research and the development of cutting-edge clinical trials. Its multidisciplinary approach fosters collaboration among experts in various fields, ensuring the highest standards of scientific rigor and ethical compliance. By leveraging its extensive resources and expertise, St. Petersburg State Pavlov Medical University aims to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
St. Petersburg, , Russian Federation
Patients applied
Trial Officials
Alexander Nemkov, PhD
Study Director
First State Pavlov Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials